169 related articles for article (PubMed ID: 11471497)
1. [Bounderies of the authorization to market and the therapeutic impass].
Samama CM
Ann Fr Anesth Reanim; 2001 Jun; 20(6):507-8. PubMed ID: 11471497
[No Abstract] [Full Text] [Related]
2. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
[No Abstract] [Full Text] [Related]
3. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
Baumgärtel MW; Eichler P; Glöckner WM; Ranze O; Greinacher A
Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
[No Abstract] [Full Text] [Related]
4. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
Lubenow N; Greinacher A
J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
[No Abstract] [Full Text] [Related]
5. Heparin-induced thrombocytopenia and its treatment.
Warkentin TE
J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S29-35. PubMed ID: 10859582
[No Abstract] [Full Text] [Related]
6. Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.
Rice L; Nguyen PH; Vann AR
Postgrad Med; 2002 Sep; 112(3):85-9. PubMed ID: 12360660
[TBL] [Abstract][Full Text] [Related]
7. [Danaparoid for anticoagulation with Cell Saver 5. Answer to the letter of A. Lorentz].
von Lüpke U
Anaesthesist; 2001 Oct; 50(10):793. PubMed ID: 11702331
[No Abstract] [Full Text] [Related]
8. Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.
Tardy B; Tardy-Poncet B; Viallon A; Piot M; Mazet E
Thromb Haemost; 1998 Sep; 80(3):530. PubMed ID: 9759647
[No Abstract] [Full Text] [Related]
9. Immediate use of anticoagulants may not improve stroke outcomes.
Am J Health Syst Pharm; 1998 Jun; 55(12):1240. PubMed ID: 9640462
[No Abstract] [Full Text] [Related]
10. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
Martin L; Machet L; Gironet N; Pouplard C; Gruel Y; Vaillant L
Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857
[No Abstract] [Full Text] [Related]
11. [Is it safe and cost effective... Danaparoid (Orgaran) as an anticoagulant for mechanical autotransfusion with Cell Saver 5 (Hemonetics),Anaesthesist (2001) 50:26-31].
Lorentz A
Anaesthesist; 2001 Oct; 50(10):792. PubMed ID: 11702330
[No Abstract] [Full Text] [Related]
12. [Heparin-induced thrombocytopenia].
Depasse F; Samama MM
Ann Biol Clin (Paris); 2000; 58(3):317-26. PubMed ID: 10846236
[TBL] [Abstract][Full Text] [Related]
13. [Delayed hypersensitivity to heparins and heparinoids].
Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia: pathophysiology and management.
Mureebe L; Silver D
Vasc Endovascular Surg; 2002; 36(3):163-70. PubMed ID: 12075381
[TBL] [Abstract][Full Text] [Related]
15. Bivalirudin as alternative to both danaparoid and heparin in off-pump coronary artery bypass grafting.
Baciewicz FA
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2108-9; author reply 2109. PubMed ID: 14688746
[No Abstract] [Full Text] [Related]
16. Ardeparin and danaparoid for prevention of deep vein thrombosis.
Med Lett Drugs Ther; 1997 Oct; 39(1011):94-5. PubMed ID: 9379998
[No Abstract] [Full Text] [Related]
17. Heparin-induced thrombocytopenia: how to manage it, how to avoid it.
Caiola E
Cleve Clin J Med; 2000 Sep; 67(9):621-4. PubMed ID: 10992619
[TBL] [Abstract][Full Text] [Related]
18. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
Cleveland KW
Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
[No Abstract] [Full Text] [Related]
19. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG.
Harenberg J; Huhle G; Wang L; Hoffmann U; Bayerl C; Kerowgan M
Allergy; 1999 May; 54(5):473-7. PubMed ID: 10380778
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
Gurbuz AT; Elliott WG; Zia AA
Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
